Clinical Trials in Maryland

Showing 12381-12400 of 19,983 trials

Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin

NCT01558570

The purpose of this protocol is to collect serum zonulin levels in people with schizophrenia. This one time visit will collect zonulin levels, antibodies to gliadin (tissue transglutaminase and antigliadin antibodies) and other information that may relate to increased intracellular tight junction permeability as it related to the immune and stress system and the immune association with kynurenic acid pathway 50. Data will be collected for use in future grant applications and published reports.

SchizophreniaCeliac Disease

University of Maryland, Baltimore100 participantsStarted Jul 2011

Catonsville, Maryland, United States

COMPLETEDPhase 415 miles

Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia

NCT00492336

This is a study of a new medication for the treatment of cognitive impairments (thinking difficulties) and negative symptoms in people with schizophrenia. The new medication is rasagiline. Rasagiline is a drug which has been approved by the Food and Drug Administration for the treatment of Parkinson's disease. It is used to treat cognitive problems.

Schizophrenia

University of Maryland, Baltimore84 participantsStarted Jan 2007

Baltimore, Maryland, United States • Catonsville, Maryland, United States • Catonsville, Maryland, United States +2 more locations

COMPLETEDPhase 315 miles

ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

NCT01980095

The "test and treat" strategy for treating dyspeptic patients who are H. pylori positive is rapidly becoming the standard of care. This study will test the effectiveness of RHB-105, a new triple therapy to treat H. pylori infection in dyspeptic patients.

DyspepsiaHelicobacter Pylori Infection

RedHill Biopharma Limited119 participantsStarted Nov 2013

Anaheim, California, United States • Anaheim, California, United States • Chino, California, United States +9 more locations

Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin

Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia

ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

Find Trials by Condition in Maryland

A Study in Second Line Metastatic Colorectal Cancer

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

A Study in Participants With Moderate to Severe Psoriasis

Riociguat in Scleroderma Associated Digital Ulcers

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Study of Ramucirumab in Ovarian Cancer

MRI to Detect Breast Tumors in Women

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Reducing Agitation in People With Dementia: the Customized Activity Trial

Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease

Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses

A Study in Advanced Solid Tumors